Deep Track Capital
Greenwich, Connecticutdeeptrackcapital.com
Overview
Deep Track Capital is a Greenwich, Connecticut-based investment firm founded in 2020 that focuses exclusively on the life sciences industry. The firm invests in both public and pre-IPO biotechnology companies, developing long-term partnerships with management teams. Its investment strategy includes leading transactions, building large syndicates, and investing in rounds led by other investors. The firm's primary focus is on biotechnology, pharmaceuticals, medical devices, diagnostics, and life sciences companies. Deep Track Capital is registered with the SEC as an investment adviser.
Portfolio Companies
46
Website
deeptrackcapital.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Draig Therapeutics | Jul 2026 | Series B | Lead |
| ARCYN Defense | Jul 2026 | Seed | Co-investor |
| Oblenio Bio | Jun 2026 | Series B | Co-investor |
| cAMPfield Therapeutics | Jun 2026 | Series A | Co-investor |
| TriveniBio | Jun 2026 | Series C | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
